Dysthymic Disorder
30
0
0
22
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
0.0%
0 terminated out of 30 trials
100.0%
+13.5% vs benchmark
30%
9 trials in Phase 3/4
45%
10 of 22 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 22 completed trials
Clinical Trials (30)
eIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk
eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients
Testing a Precision Psychotherapy System for Low-income Patients
Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older Adults
Effects of Therapist Behavior on the Treatment of Depressed Adolescents
A Comparison of Medication Augmentation and PST in the Treatment of Depression in Older Adults
RECOVERY: A Transdiagnostic Intervention for Anxiety and Depression
Clinical Trial of CBASP for Individuals With Co-occurring Chronic Depression and Alcohol Dependence
Rumination Focus Cognitive Behavior Therapy
Schema Therapy for Chronic Depression
Desvenlafaxine vs. Placebo Treatment of Chronic Depression
Duloxetine for Chronic Depression: a Double-blind Study
Cognitive Therapy for Unipolar Depression: Efficacy of a Dilemma-Focused Intervention
The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels
Treatment for Depressed, Obese Individuals at Risk for Cardiovascular Disease (CVD)
Internet-delivered Transdiagnostic Intervention for Anxiety and Depression
Motivational Interviewing and Cognitive Behavioral Therapy-based Intervention for Cardiovascular Disease Prevention Amongst American Indians With Diabetic and Depressive Symptoms
Wellbutrin XL for Dysthymic Disorder
Escitalopram in the Treatment of Dysthymic Disorder, Double Blind
Desvenlafaxine Monotherapy in Dysthymia